Skip to main content

Table 2 Descriptions of complications in the study group of the included studies

From: The efficacy of intraoperative periarticular injection in Total hip arthroplasty: a systematic review and meta-analysis

Author, year

Enrolled Sample number (G1/G2)

Descriptions of complications in study group

Conclusion

Hirasawa, 2018 [14]

45/45

No complication including surgical site infection, wound complications, prolonged numbness or weakness, or allergy to the medication

No difference

Ban WR,2017 [5]

43/43

No mention

N/A

Villatte, 2016 [6]

75/75

Wound septic complication (2 hips, treatment group)

No difference

Hofstad, 2015 [10]

55/54

No mention

N/A

den Hartog, 2015 [11]

25/25

Dizziness, hypotension and retention of urine

No difference

Zoric, 2014 [12]

29/29

Nausea and vomiting

No difference

Dobie, 2012 [15]

46/46

Hypotension, chest pain, dural leak

No difference

Murphy, 2012 [7]

45/46

Urinary retention

No difference

Andersen, 2011 [16]

12/12

No clinical side effect, including cardiac and hemodynamic changes

No difference

Lunn, 2011 [13]

60/60

Quadriceps muscle palsy

No difference

Liu, 2011 [8]

40/40

Hemodynamic change, nausea and vomiting, urinary retention, respiratory depression, rash, and deep vein thrombosis

No difference

Busch, 2010 [9]

32/31

Wound blister, prominent suture trimming and deep vein thrombosis (4 hips, 3 in the treatment group and 1 in the control group)

No difference

  1. G1: study group(PAI); G2: control group (no PAI)
  2. N/A non applicable